25 / 62
DCMS online
. org
Northeast Florida Medicine
Vol. 67, No. 1 2016
25
Palliative Care
Lancet Oncol. 2014 Nov;15(12):1397-406.
30. Sartor O, Coleman R, Nilsson S, Heinrich D, et al.
Effect of radium-223 dichloride on symptomatic skel-
etal events in patients with castration-resistant prostate
cancer and bone metastases: results from a phase 3,
double-blind, randomised trial. Lancet Oncol. 2014
Jun;15(7):738-46.
31. Fairchild A, Harris K, Barnes E, et al. Palliative thoracic
radiotherapy for lung cancer: a systematic review. J Clin
Oncol. 2008 Aug 20;26(24):4001-11.
32. Yu JB, Wilson LD, Detterbeck FC. Superior vena
cava syndrome--a proposed classification system and
algorithm for management. J Thorac Oncol. 2008
Aug;3(8):811-4.
33. Ung YC, Yu E, Falkson C, et al. The role of high-dose-
rate brachytherapy in the palliation of symptoms in
patients with non-small-cell lung cancer: a systematic
review. Brachytherapy. 2006 Jul-Sep;5(3):189-202.
34. Caspers RJ, Welvaart K, Verkes RJ, et al. The effect
of radiotherapy on dysphagia and survival in pa-
tients with esophageal cancer. Radiother Oncol. 1988
May;12(1):15-23. PubMed PMID: 2457230.
35. Coia LR, Soffen EM, Schultheiss TE, et al. Swallowing
function in patients with esophageal cancer treated with
concurrent radiation and chemotherapy. Cancer. 1993
Jan 15;71(2):281-6.
36. Rajendran RR, Jabbari S, Hartsell WF. Palliation of
Visceral Recurrences and Metastases and Treatment of
Oligometastatic Disease. In: Perez and Brady’s Prin-
ciples and Practice of Radiation Oncology, 6th ed.
Philadelphia, Pa: Lippincott Williams & Wilkins; 2013.
p. 1778-1790.
37. Warde P, Mason M, Ding K, et al. Combined androgen
deprivation therapy and radiation therapy for locally
advanced prostate cancer: a randomised, phase 3 trial.
Lancet. 2011 Dec 17;378(9809):2104-11.
38. Temel JS, Greer JA, Muzikansky A, et al. Early palliative
care for patients with metastatic non-small-cell lung
cancer. N Engl J Med. 2010 Aug 19;363(8):733-42.